Biosimilar drugs could save up to $110 billion by 2020 - IMS : Lower-cost copies of complex biotech drugs, known as biosimilars,
Biosimilar drugs could save up to $110 billion by 2020 - IMS : Lower-cost copies of complex biotech drugs, known as biosimilars, could save the United States and Europe's five top markets as much as 98 billion euros ($110 bln) by 2020, a new analysis showed on Tuesday.
Source: reuters.com
Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological
Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey Lars G Hemkens. Despina G Contopoulos-Ioannidis. John P A Ioannidis. BMJ.
Source: bmj.com
Canada court orders tobacco companies to set aside almost C$1 billion: A Canadian appeal court on Tuesday ordered two major
Canada court orders tobacco companies to set aside almost C$1 billion: A Canadian appeal court on Tuesday ordered two major tobacco companies to set aside a combined C$984 million ($742 million) while they challenge billions of dollars in damages awarded to smokers in the province of Quebec.
Source: reuters.com
Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug
Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study Anne-Marie Schjerning Olsen. Jesper Lindhardsen. Gunnar H Gislason. Patricia McGettigan. Mark...
Source: bmj.com
RSS feed